Bicalutamide

Details About Generic Salt ::  Bicalutamide  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS BICALUTAMIDE NONSTEROIDAL ANTI-ANDROGEN | ANTI-NEOPLASTIC PK: A: Rapid...

Lomustine

Details About Generic Salt ::  Lomustine  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS LOMUSTINE ALKYLATING DRUG (NITROSOUREA) | ANTI-NEOPLASTIC PK: A: Complete...

Bleomycin

Details About Generic Salt ::  Bleomycin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS BLEOMYCIN CYTOTOXIC GLYCOPEPTIDE ANTIBIOTIC | ANTI-NEOPLASTIC PK: A: Rapid...

Melphalan

Details About Generic Salt ::  Melphalan  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS MELPHALAN ALKYLATOR | ANTI-NEOPLASTIC PK: A: Variable & incomplete (PO)...

Capecitabine

Details About Generic Salt ::  Capecitabine  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS CAPECITABINE FLUOROPYRIMIDINE, ANTIMETABOLITE (PYRIMIDINE ANALOG) |...

Mitomycin

Details About Generic Salt ::  Mitomycin  Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents 18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS MITOMYCIN ANTIBIOTIC | ANTI-NEOPLASTIC PK: D: 22 L/m2 (Vd) M: Hepatic E:...

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.

I accept I decline